Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Western diet fuels IBD by derailing the microbiome - can precision nutrition turn the tide?

12

Oct 2025

Western diet fuels IBD by derailing the microbiome - can precision nutrition turn the tide?

This review examines how Western dietary patterns, high in ultra-processed foods, salt, and unhealthy fats, disrupt gut microbiota, impair immune regulation, and contribute to the global rise of inflammatory bowel disease (IBD). It highlights systems biology and nutritional epidemiology as essential tools to develop personalised dietary strategies and shift IBD care from treatment to prevention.

Why your diet may be exporting extinction abroad without you knowing

12

Oct 2025

Why your diet may be exporting extinction abroad without you knowing

This global analysis shows that the biodiversity impact of producing 1 kg of food can vary by up to 1,000-fold, with ruminant meat and tropical luxury crops carrying the highest extinction risks. Using the LIFE metric, researchers reveal how national diets and food imports contribute to hidden biodiversity losses, highlighting dietary shifts as a powerful conservation tool.

Home blood tests could spot early heart risks in young adults

12

Oct 2025

Home blood tests could spot early heart risks in young adults

Self-administered dried blood spot kits show potential for cardiometabolic screening in young adults, but success relied heavily on clear guidance and researcher support. High rates of at-risk biomarkers highlight an urgent need for early prevention in this population.

Can drones become the frontline of medical delivery in flood-hit regions?

12

Oct 2025

Can drones become the frontline of medical delivery in flood-hit regions?

Researchers modeled drone-based medication delivery across Virginia’s isolated Eastern Shore, finding it could cut travel times from nearly 50 minutes by car to under 10 minutes for most residents. By mapping age, flood risk, and access barriers, the study highlights how targeted drone networks could improve health equity in rural, disaster-prone regions.

From stress to susceptibility: how COVID lockdowns shaped teen vaping risk

12

Oct 2025

From stress to susceptibility: how COVID lockdowns shaped teen vaping risk

Teenagers who experienced higher COVID-19 stress during remote schooling were more likely to become open to trying vaping, which significantly increased their odds of using e-cigarettes and cannabis two years later. The study reveals that susceptibility, not immediate use, was the critical pathway linking early stress to later vaping behaviors.

Could belonging be a biological shield? Researchers uncover aging clues

12

Oct 2025

Could belonging be a biological shield? Researchers uncover aging clues

Researchers analyzing over 2,100 adults from the MIDUS cohort found that individuals with higher cumulative social advantage, spanning community ties, family relationships, and religious support, showed slower biological aging and lower systemic inflammation. The findings suggest that long-term social resources may become biologically embedded, influencing molecular pathways linked to longevity.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.